We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$999B
AUM Growth
+$24.7B
Cap. Flow
-$14B
Cap. Flow %
-1.41%
Top 10 Hldgs %
24.27%
Holding
2,908
New
248
Increased
1,171
Reduced
1,334
Closed
66

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$3.3B
2
LLY icon
Eli Lilly
LLY
+$2.75B
3
AZN icon
AstraZeneca
AZN
+$1.98B
4
CPNG icon
Coupang
CPNG
+$1.54B
5
FTNT icon
Fortinet
FTNT
+$1.48B

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$2.34B
2
MS icon
Morgan Stanley
MS
+$2.26B
3
ABNB icon
Airbnb
ABNB
+$2.04B
4
QCOM icon
Qualcomm
QCOM
+$1.95B
5
NVDA icon
NVIDIA
NVDA
+$1.81B

Sector Composition

Rank Sector Weight
1 Technology 23.35%
2 Healthcare 16.19%
3 Consumer Discretionary 15.55%
4 Financials 12.84%
5 Communication Services 12.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALTO icon
2801
Alto Ingredients
ALTO
$326M
$60K ﹤0.01%
11,000
CLIR icon
2802
ClearSign Technologies
CLIR
$28M
$59K ﹤0.01%
+1,040
New +$45.6K
USWS
2803
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$59K ﹤0.01%
+2,714
New +$70.3K
INUV icon
2804
Inuvo
INUV
$14.6M
$58K ﹤0.01%
+5,660
New +$68.4K
WPG
2805
DELISTED
Washington Prime Group Inc.
WPG
$57K ﹤0.01%
+25,700
New +$188K
KRMD icon
2806
KORU Medical Systems
KRMD
$157M
$56K ﹤0.01%
+16,026
New +$69.4K
HIL
2807
DELISTED
Hill International, Inc. Common Stock
HIL
$56K ﹤0.01%
+17,600
New +$45.5K
OTIC
2808
DELISTED
Otonomy, Inc.
OTIC
$55K ﹤0.01%
21,700
ONCS
2809
DELISTED
OncoSec Medical Incorporated
ONCS
$54K ﹤0.01%
518
LTRX icon
2810
Lantronix
LTRX
$276M
$51K ﹤0.01%
+11,200
New +$53K
TIO
2811
DELISTED
Tingo Group, Inc. Common Stock
TIO
$50K ﹤0.01%
+24,300
New +$55.3K
LGMK
2812
DELISTED
LogicMark
LGMK
$48K ﹤0.01%
+7
New +$55.4K
TOON icon
2813
Kartoon Studios
TOON
$38.9M
$48K ﹤0.01%
+2,450
New +$46.6K
BRN icon
2814
Barnwell Industries
BRN
$14M
$47K ﹤0.01%
+18,200
New +$50.5K
DALN
2815
DELISTED
DallasNews
DALN
$47K ﹤0.01%
5,578
LPTH icon
2816
Lightpath Technologies
LPTH
$851M
$47K ﹤0.01%
15,300
-31,600
-67% -$120K
KDMN
2817
DELISTED
Kadmon Holdings, Inc.
KDMN
$46K ﹤0.01%
11,746
-69
-0.6% -$316
AWRE icon
2818
Aware
AWRE
$26.2M
$44K ﹤0.01%
12,000
KG
2819
Kestrel Group
KG
$66.3M
$40K ﹤0.01%
+600
New +$32.2K
SVRA icon
2820
Savara
SVRA
$1.13B
$40K ﹤0.01%
19,003
+7,200
+61% +$12.3K
FPAY
2821
DELISTED
FlexShopper
FPAY
$34K ﹤0.01%
+13,300
New +$40.2K
NAT icon
2822
Nordic American Tanker
NAT
$1.41B
$33K ﹤0.01%
+10,283
New +$33.1K
VSTM icon
2823
Verastem
VSTM
$610M
$29K ﹤0.01%
984
+2
+0.2% +$56
CRBP icon
2824
Corbus Pharmaceuticals
CRBP
$189M
$23K ﹤0.01%
381
+19
+5% +$1.25K
ACGN
2825
DELISTED
Aceragen Inc
ACGN
$21K ﹤0.01%
960

Similar funds

T. Rowe Price Associates's Q1 2021 Portfolio in Review

As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
  • T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
  • T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
  • T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
  • T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
  • T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
  • T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.

Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.